条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Genes Cells, 12, 773-785 (2007). 伊藤　誠二 E14.1 [129P2/OlaHsd] C（3〜6か月） Ovo12遺伝子exon 3 のtargeted mutation,E8より心血管系生に異常が見られ、E9-E10に死亡 RBRC02891 C (3-6 months) Ovo12遺伝子exon 3 のtargeted mutationE8より心血管系生に異常が見られ、E9-E10に死亡 B6;129P2-Ovol2<tm1Iiu> B6;129P2-Ovol2<tm1Iiu> true Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Genes Cells, 12, 773-785 (2007). Cre/loxP system Seiji ITO Phage P1 loxP site, mouse Ovo12 genomic DNA <a href='https://brc.riken.jp/mus/pcr02891'>Genotyping protocol -PCR-</a> ヘテロで交配維持する B6はC57BL/6JJmsSlc Ovo12-KO, Movo-KO Ovo12-KO, Movo-KO ヘテロで交配維持するB6はC57BL/6JJmsSlc